University of Pennsylvania
3451 Walnut
Philadelphia
Pennsylvania
19104
United States
Tel: 215-898-5000
Website: http://www.upenn.edu/
459 articles with University of Pennsylvania
-
Cerebral Therapeutics™ to Present Clinical Data at Antiepileptic Drug and Device Trials XV Conference
5/16/2019
Cerebral Therapeutics™ announced that the Company will present at the Antiepileptic Drug and Device Trials XV conference, which is held every two years and is sponsored by The Epilepsy Study Consortium in collaboration with the University of Pennsylvania and the Epilepsy Foundation.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
The first clinical trials using CRISPR technology are expected to get underway in the United States, even as echoes of a scandal involving the use of CRISPR on embryos in China are still being felt across the globe.
-
Amid Reports That Chinese Researcher May Have Used CRISPR to Edit Cholesterol Gene, He's Gone Mis...
12/4/2018
At least one U.S. researcher who was in touch with He Jiankui and his team speculates that the second pregnancy may involve a baby or babies whose PCSK9 gene was editing using CRISPR. PCSK9 is involved in control of cholesterol. -
Immuno-oncology comes pretty close to being a miracle cure for certain types of cancer. But it's not perfect, and a recently reported isolated case demonstrates that there are risks.
-
Preventable Hospital Readmissions Cut by More Than 25 Percent Under Innovative Contract Between University of Pennsylvania Health System and Independence Blue Cross
11/16/2018
A year into new collaboration, Penn Medicine and Independence announce unprecedented results
-
Cabaletta Bio launched out of the University of Pennsylvania with an exclusive license deal and two multi-year sponsored research agreements. The fledgling biotech company will work on engineered T cell products for B cell-mediated autoimmune disease.
-
BioNTech and the University of Pennsylvania Enter into Strategic Research Collaboration to Develop mRNA Vaccine Candidates Against Various Infectious Diseases
11/5/2018
New research program between BioNTech and the University of Pennsylvania
-
Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Best Disease)
10/31/2018
Ophthotech Enters into Second Series of Gene Therapy Agreements with the University of Pennsylvania and the University of Florida for Exclusive Option for Novel Product Candidates to Treat Best Disease
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Why Does Immunotherapy Cost So Much?
10/4/2018
As cancers develop treatment resistance, combinations of old and new therapies will become increasingly important to effective treatment. The use of multiple, potentially costly, drugs during combination therapy, increased duration of novel therapies and the possibility of patients needing multip... -
“Rising Star Award” in Neurodegenerative Research – Call for Submissions
10/2/2018
The Mahoney Institute for Neurosciences (MINS) at the Perelman School of Medicine of the University of Pennsylvania is pleased to announce an international call for submissions for its annual Rising Star Award in neuroscience research.
-
Precision Biosciences Announces Collaboration with University of Pennsylvania to Develop Genome Editing Therapeutics
9/4/2018
Precision BioSciences today announced an expansion of their ongoing collaboration with the Gene Therapy Program in the Perelman School of Medicine at the University of Pennsylvania.
-
Kymriah® (tisagenlecleucel, formerly CTL019) receives European Commission Approval
8/28/2018
Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE:OXB), a leading gene and cell therapy group, today notes that the European Commission (EC) has approved the Novartis CAR-T cell therapy, Kymriah® (tisagenlecleucel, formerly CTL019).
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
First Mouse Model to Mimic Lung Disease Could Speed Discovery of More Effective Treatments
8/16/2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability to fully model the disease in animals, limiting the ability to observe and understand the disease.
-
CRISPR, the gene editing technique that promises designer babies, to end to all disease as we know it, and biohacking where individuals could change their own genome to include that of fluorescent jellyfish or lobster claws, seems to have more problems than originally thought.
-
Johnson & Johnson Innovation Announces JPOD @ Philadelphia to Accelerate Healthcare Innovation in Philadelphia's Ecosystem
7/18/2018
JLABS will also launch a QuickFire Challenge to nurture local innovation
-
Phase III study shows quizartinib prolongs overall survival for patients with deadly type of relapsed or refractory AML
6/18/2018
A study led by The University of Texas MD Anderson Cancer Center revealed that the investigational drug quizartinib prolonged overall survival for patients with a deadly form of acute myeloid leukemia (AML).
-
CHOP's Center for Autism Research Shows How the Brain's "Reward Circuit" Plays a Key Role in Symptoms of Autism Spectrum Disorder
6/18/2018
Neuroimaging reveals differences in rewards processing linked to social difficulties, repetitive behaviors and restricted interests in ASD